EPP 16th Life Sciences
Pricing Forum 2026
Agenda
14:00
WORKSHOP 1
From Data Chaos to Pricing Intelligence: Your AI Readiness Roadmap
- Audit your current data maturity honestly: what do you actually have vs. what AI requires?
- Map the minimum viable data architecture to deploy AI pricing tools in 12 months
- Avoid the three most common implementation failures: vendor lock-in, black-box decisions, and change resistance
15:00
WORKSHOP 2
Pricing Under Inflation: Protecting Margin When the Ceiling Won’t Move
- Build a contract renegotiation toolkit your finance team and distributors will actually accept
- Model four scenarios: do nothing, cost-cut, creative pricing, and hybrid, and stress-test each against budget freeze
16:00
WORKSHOP 3
MFN Policy War Room: Stress-Testing Your European Launch Sequence
- Run live scenarios: what happens to your Swiss, German, and UK launch prices if US net prices become transparent?
- Rebuild your launch sequencing logic under three MFN trajectories: mild, moderate, and full enforcement · Leave with a country-by-country risk matrix and a playbook for your next global pricing committee
17:30
Workshop Close & Pre-Forum Welcome Drinks Reception
08:00
Welcome Coffee & Registration
08:30
Opening Remarks – EPP Pricing Platform
The Forces to Watch in 2026
08:40
KEYNOTE
Keynote Built for Uncertainty: The New Operating Model for Global Pricing & Market Access
- Stop forecasting the future: start building a pricing function that performs across multiple scenarios
- The war-room model in practice: how leading teams run best, base, and worst-case scenarios as a permanent discipline, not a crisis response
- From reactive to resilient: the structural changes (people, process, and governance) that separate pricing functions that bend from those that break
09:10
KEYNOTE
MFN Is Not a US Problem, It Is Your European Problem, Starting Now
- Map exactly which of your markets reference the US, and quantify the price erosion risk if US net prices become transparent
- Protect your in-licensing pipeline: why low Swiss and German reference prices are already making global partners rethink European deals, and how to get ahead of it
- Walk away with a country-by-country risk assessment framework your pricing committee can use at the next quarterly review
09:40
PANEL DISCUSSION
Geopolitical Chaos, Budget Freezes, and Supply Chain Shocks: How Are Pricing Teams Actually Coping?
- Panellists share their real pricing war-room set-ups: who is in the room, how often, what triggers a scenario review?
- The Middle East conflict, Ukraine, and oil prices: how global instability is changing commercial strategy at the country level
- Learn with senior leaders what decisions did they get wrong in the last 18 months, and what would they do differently
10:20
Networking Break
Market Access & Reimbursement Realities
11:00
KEYNOTE
When Reimbursement Fails: Building Value and Sustaining Pricing Without Payer Support
- Pricing roadmap for unfunded markets and indirect reimbursement: the MedTech DRG reality, mapped step by ste
- Identify who actually controls the purchasing decision when the payer isn’t in the room, and how to build the right case for the right stakeholder
- Three real examples of companies that priced and sold successfully without direct reimbursement, the moves that worked, the mistakes that cost them, and what you can replicate tomorrow
11:30
KEYNOTE
Uncover the Markets You Can’t Afford to Ignore Anymore
- Identify where the real commercial opportunity sits in Central & Eastern Europe and MENA: the markets that are ready now versus the ones still two years away
- Structure licensing and distribution agreements that protect your global price architecture: the clauses that prevent local deals from creating IRP problems in your core markets
- Navigate the reimbursement and access realities on the ground: who the real decision-makers are, what evidence they require, and how to localise your value story without rebuilding it from scratch
12:00
KEYNOTE
Outcomes-Based Contracts in Practice: What the Case Studies Don’t Tell You
- Structure and operationalise an outcomes-based contract aligned with HTA expectations, the mechanics that make or break it
- The data infrastructure you actually need to run a performance contract: what nobody tells you before you sign
- Italy, Germany, France: how risk-sharing models are playing out in practice and what pricing teams wish they had known at launch
12:30
KEYNOTE
From Negotiation to Partnership: The Mindset Shift That Unlocks the Value
- From product price to pathway value: how to quantify what your treatment does to the whole care system (hospitalisations avoided, workforce shifts, primary care delegation) in a language payers can no longer dismiss
- Affordability as a design principle, not a concession: why companies that build sustainable pricing models from the patient and system perspective up are gaining access their competitors are losing
- Shape it or have it forced on you: the honest conversation about where the industry-payer relationship has to go next — and what you personally have to change to get there
10:20
Networking Lunch
12:30
DEEP DIVE ROUNDTABLES
Pick Your Problem: Peer-Led Deep Dives on the Challenges Keeping You Awake
Choose the table that matches your most pressing challenge.
ROUNDTABLE 1
MFN & Reference Pricing Cascades — Protecting Your Global Price Architecture
ROUNDTABLE 2
AI Maturity in Pricing — From Chatbots to Real Decision Support: Where Are You, Really?
ROUNDTABLE 3
MedTech Commodity Pricing Under Inflation — What Contracts, Clauses, and Creative Models Actually Work
ROUNDTABLE 4
Talent, Storytelling, and C-Suite Buy-In — The Soft Skills That Decide Whether Your Strategy Gets Funded
ROUNDTABLE 5
Rare Disease Access — When the Evidence Bar Keeps Rising and the Patient Population Stays Small
15:00
Networking Break
AI, Digital Transformation & the Pricing Function
15:30
KEYNOTE
AI in Pharma Pricing: What Executives Who’ve Actually Implemented It Will Tell You
- The honest scorecard: which use cases delivered ROI, which consumed budget and went nowhere, and why
- Governance and regulatory alignment — how do you explain an AI-generated pricing decision to a regulator who demands transparency?
- From AI experiment to enterprise deployment: the organisational change management nobody budgeted for
16:00
KEYNOTE
AI in Pharma Pricing: What Executives Who’ve Actually Implemented It Will Tell You
- How medical device companies are using AI for tender optimisation and customer segmentation despite fragmented data infrastructure
- The MedTech data problem: you can’t skip straight to AI — here are the three foundational steps you must take first
- Real use cases from the MedTech field: what improved, what broke, and what surprised the team
16:30
PANEL DISCUSSION
Price & Access in an AI-Driven World: Is Your Function Ready or Just Talking About It?
- Panellists reveal where they honestly sit on the AI maturity curve — and what the gap between aspiration and reality looks like
- The generational problem: tech-native junior staff can prompt, but can they judge? Senior staff can judge, but can they prompt?
17:00
PANEL DISCUSSION
AI in Tendering: The Early Movers Playbook
- See a real implementation: how AI is already being used to analyse tender documents, model bid scenarios, and optimise submission decisions, not in theory, but in live markets today
- Understand the competitive shift coming when AI becomes standard on both sides of the table: payers using AI to set terms, companies using AI to respond, and how to position yourself ahead of it
- Walk away with a practical adoption roadmap: the first three moves a pricing and tendering team should make to build AI capability without overhauling their entire function
17:30
End of Day 1 — Networking Dinner
08:00
Welcome & Networking
09:00
Day 2 Opening — Insights from Day 1 Research Summary
Forum Chair opens with synthesised themes from Day 1 discussions — practitioner perspectives anonymised and aggregated in real time.
Value-Driven Perspectives
09:10
KEYNOTE
Explore How Innovative Contracting Can Open New Opportunities
- Understand the structural barriers that make outcomes-based and risk-sharing contracts collapse before they scale such as data gaps, legal complexity, and misaligned incentives
- Explore the full menu of contracting options available today: annuity models, volume caps, outcome milestones, and managed entry agreements, with honest assessments of each
- Learn what is changing in the operating environment that could finally make innovative contracting the default, not the exception
09:40
KEYNOTE
Rethinking Your Launch Sequencing: How to Rebuild Your Global Go-to-Market Logic
- How to re-think the traditional sequencing model as it no longer protects your price architecture under MFN and IRP pressure
- Map the new sequencing trade-offs: speed vs. price protection, access vs. reference risk, early markets vs. strategic markets
- Build a flexible launch framework that adapts to market signals in real time rather than locking you into a sequence decided two years before launch
10:10
KEYNOTE
Protecting Innovation in Europe: The Policy Fight That Will Define the Next Decade
- Understand the legislative and policy forces (pharma regulation reform, HTA, compulsory licensing debates) that are actively undermining Europe’s attractiveness for R&D investment
- What the industry must do differently to make the economic and societal case for innovation before governments make the decision for them
- The role pricing and market access professionals play in advocacy — and why staying out of the policy conversation is no longer a neutral position
10:40
Networking Break
12:30
MID-MORNING ROUNDTABLES — DEEP DIVES CONTINUED
Pick Your Problem: Peer-Led Deep Dives on the Challenges Keeping You Awake
Choose the table that matches your most pressing challenge.
ROUNDTABLE 1
Launch Sequencing Under MFN Pressure — Rebuilding Your Go-to-Market Logic from Scratch
ROUNDTABLE 2
Precision Therapies and Orphan Drugs — When the Evidence Bar Rises Faster Than Your Data Can
ROUNDTABLE 3
Emerging Markets in Global Pricing — When Brazil, China, and Southeast Asia Stop Being Afterthoughts
ROUNDTABLE 4
Digital Health Pricing and Reimbursement — New Product Categories, Old Reimbursement Frameworks
ROUNDTABLE 5
Pricing Governance — Who Really Controls Your Price? And Should They?
12:10
KEYNOTE
Medicines Affordability: The Conversation Industry Keeps Avoiding — and Why It Can’t Anymore
- Why affordability is no longer just a global health issue, it is a European access crisis that is reshaping what payers will and won’t reimburse
- How the Medicines Affordability & Adherence Alliance framework redefines the value chain conversation, and what pricing leaders can learn from it
- The affordability-by-design approach: how to build sustainable pricing models that serve patients, satisfy payers, and protect commercial viability simultaneously
12:40
Networking Lunch
Forward-Looking Perspectives & Closing Programme
14:00
KEYNOTE
The Skills Gap Nobody Talks About: Why Your Pricing Strategy Fails Without Soft Skills
- Understand why storytelling, stakeholder influence, and change management are now core pricing competencies, not optional extras
- The generational problem in pricing teams: senior experience without digital fluency meets digital fluency without business judgment, and how to bridge the gap deliberately
- Build the internal capability to get C-suite buy-in for pricing decisions that are technically correct but commercially invisible without the right narrative
14:30
KEYNOTE
When the Payer Runs Out of Money: Pricing in an Era of Permanent Budget Pressure
- European healthcare budgets are not temporarily constrained — they are structurally limited. What that means for every negotiation you will have in the next five years
- How payers are changing their decision criteria when budgets freeze: what still gets funded, what gets cut, and what gets delayed indefinitely
- Adapt your value story for a payer audience that has stopped asking “does it work?” and started asking “can we afford it?”
15:00
KEYNOTE
The Pricing Value Chain: Every Function You Work With Is Also a Pricing Decision-Maker
- How pricing interacts with supply chain, commercial, legal, and R&D in ways that are systematically underestimated — and how to map them
- The hidden cost of poor internal pricing coordination: margin leakage, tender losses, and delayed launches that nobody traced back to misalignment
- Build a pricing governance model that spans the whole value chain without creating bureaucratic paralysis
15:30
KEYNOTE
What Will the Pricing Function Look Like in 2030? A Provocative Forecast
- AI will not eliminate pricing jobs — but it will eliminate pricing roles that fail to evolve. Here is the evolution map
- The skills gap is real and getting worse: multidisciplinary talent who understand data, pharma, and AI simultaneously does not exist yet at scale
- Your 2030 team will be smaller, faster, and more influential — if you start building it now. Here is where to start
16:00
Closing Remarks
16:30
Closing Networking Drinks & End of Forum
Training
Enhance your Forum experience with the Combo Pass – gain RGM expertise through both Training and the Forum.
Economic Value Modeling Training
Gain the expertise to develop pricing strategies anchored in real customer value.
Learn to quantify, communicate, and monetize value effectively using the Economic Value Modeling (EVM) framework—covering creation, pricing, communication, and selling. Drive profitability by ensuring your prices reflect the true value you deliver.
Find out more details HERE
Subscription Pricing Training
Learn how to design customer-centric packaging models, drive monetization, and lead pricing transformations in complex B2B environments.
This program provides the tools and frameworks needed to turn pricing into a strategic growth driver. Gain the confidence to manage change, avoid common pitfalls, and build a scalable and effective pricing function.
Find out more details HERE
Strategies & Tactics for Pricing
Learn and apply essential pricing processes, strategies, and tactics to improve your organization’s margin. Discover both classic and innovative price-setting methods, understand the factors influencing price, and manage price pressure effectively. You’ll benefit from real-life case studies, interactive practices, and peer learning to enhance your pricing expertise and drive business success.